跳到正文
UChicagoCancerCenter· @UCCancerCenter · X·· 2026-04-21评分60
正文 · 原文

At #AACR26, Yijia Sun presents validation data supporting performance of recently developed PRS. Importantly, a new streamlined 162-SNP TNBC PRS demonstrate consistent, cost-efficient potential that can advance more equitable and precise risk assessment. ⁦
@UChicagoPHS
⁩

热度 4 · 2 赞 · 0 回复 · 2 转发

来源:UChicagoCancerCenter · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org